MedTrace Logo

Promiseb Topical Cream for Cradle Cap

NCT01214434 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2017-03-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.

Conditions

  • Cradle Cap
  • Infantile Seborrheic Dermatitis

Interventions

DEVICE

Promiseb Topical Cream

topical non steroidal cream, twice daily

OTHER

Bland emollient

Eucerin cream twice daily

Sponsors & Collaborators

  • Promius Pharma, LLC

    lead INDUSTRY

Principal Investigators

  • Joanne M Fraser, PhD · Promius Pharma

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-06-30
Completion
2011-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01214434 on ClinicalTrials.gov